Canada Markets close in 4 hrs 46 mins

Satsuma Pharmaceuticals, Inc. (STSA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
23.38-0.62 (-2.58%)
As of 11:02AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 5407.03M
Enterprise Value 3328.11M
Trailing P/E N/A
Forward P/E 1-7.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.33
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.59

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 3N/A
52 Week High 336.10
52 Week Low 38.61
50-Day Moving Average 326.33
200-Day Moving Average 324.00

Share Statistics

Avg Vol (3 month) 379.81k
Avg Vol (10 day) 385.38k
Shares Outstanding 517.41M
Float 6.99M
% Held by Insiders 111.91%
% Held by Institutions 177.85%
Shares Short (Jul. 30, 2020) 4259.84k
Short Ratio (Jul. 30, 2020) 44.09
Short % of Float (Jul. 30, 2020) 43.94%
Short % of Shares Outstanding (Jul. 30, 2020) 41.49%
Shares Short (prior month Jun. 29, 2020) 4155.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.26%
Return on Equity (ttm)-57.65%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -43.23M
Net Income Avi to Common (ttm)-42.11M
Diluted EPS (ttm)-11.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)93.7M
Total Cash Per Share (mrq)5.38
Total Debt (mrq)3.99M
Total Debt/Equity (mrq)4.24
Current Ratio (mrq)15.11
Book Value Per Share (mrq)7.03

Cash Flow Statement

Operating Cash Flow (ttm)-41.52M
Levered Free Cash Flow (ttm)-27.69M